Kirkland & Ellis advised HealthCor Catalio Acquisition Corp. on the deal.
HealthCor Catalio Acquisition Corp., a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses, priced its upsized initial public offering of 18,000,000 Class A ordinary shares at a price of $10 per share. The Company’s sponsor is owned by affiliates of HealthCor Management, L.P., which manages approximately $2.7 billion in assets across long/short and long only healthcare funds, and Catalio Capital Management, LP, a private equity firm that invests in breakthrough biomedical technology companies. The Company will be listed on the Nasdaq Capital Market and trade under the ticker symbol “HCAQ” beginning on Jan. 27, 2021.
Jefferies LLC is serving as sole book-running manager for this offering.
The Kirkland team advising HealthCor Catalio Acquisition was led by capital markets partners Christian Nagler (Picture) and Debbie Yee and associates Noah Allen, Austin Elliott, Sami Ghubril and Sam Roberts; and tax partners Mike Beinus, Vivek Ratnam and Meredith Levy.
Involved fees earner: Noah Allen – Kirkland & Ellis; Michael Beinus – Kirkland & Ellis; Austin Elliott – Kirkland & Ellis; Sami Ghubril – Kirkland & Ellis; Meredith Levy – Kirkland & Ellis; Christian Nagler – Kirkland & Ellis; Vivek Ratnam – Kirkland & Ellis; Sam Roberts – Kirkland & Ellis; Debbie Yee – Kirkland & Ellis;
Law Firms: Kirkland & Ellis;
Clients: HealthCor Catalio Acquisition;